3/ Possible Chronic Disease Risk Reduction

Cardiovascular Health: semaglutide a GLP-1-RA has shown promise of lifespan extension in obese individuals by reducing the risk of cardiovascular disease. (12)

Preclinical evidence also indicates improved endothelial function via…